trial
as of 2026-07-01SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
NCTId NCT04528095
at a glance
Phase 3 · Unknown
Enrollment 162 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2022-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Unknown
Enrollment
162 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Sequential
Masking
Single
Start
2020-12
Primary completion
2022-12
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Shanghai Mental Health CenterLead Sponsor
Investigators
1
Dengtang Liu, MDStudy Chair
Sites
1 total
Shanghai, China
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
162
Phase
PHASE3
Primary Completion Date
2022-12
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
indication
indication
indication
indication
investigator
person